Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line.

MLA

Elnawasany, Sally, et al. “Anti-Cancer Effect of Nano-Encapsulated Boswellic Acids, Curcumin and Naringenin against HepG-2 Cell Line.” BMC Complementary Medicine and Therapies, vol. 23, no. 1, July 2023, p. 270. EBSCOhost, https://doi.org/10.1186/s12906-023-04096-4.

APA

Elnawasany, S., Haggag, Y. A., Shalaby, S. M., Soliman, N. A., El Saadany, A. A., Ibrahim, M. A. A., & Badria, F. (2023). Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line. BMC Complementary Medicine and Therapies, 23(1), 270. https://doi.org/10.1186/s12906-023-04096-4

Chicago

Elnawasany, Sally, Yusuf A Haggag, Shahinaz M Shalaby, Nema A Soliman, Amira A El Saadany, Marwa A A Ibrahim, and Farid Badria. 2023. “Anti-Cancer Effect of Nano-Encapsulated Boswellic Acids, Curcumin and Naringenin against HepG-2 Cell Line.” BMC Complementary Medicine and Therapies 23 (1): 270. doi:10.1186/s12906-023-04096-4.